Prism Advisors, Inc. Alaunos Therapeutics, Inc. Transaction History

Prism Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 26, 2018	SELL	$2.26 - $3.27 $39,168 - $56,672	-17,331 Closed	0 $0
Q2 2018 Jul 13, 2018	SELL	$3.02 - $4.94 $4,472 - $7,316	-1,481 Reduced 7.87%	17,331 $55,000
Q1 2018 May 09, 2018	BUY	$3.46 - $5.14 $14,123 - $20,981	4,082 Added 27.71%	18,812 $87,000
Q4 2017 Feb 12, 2018	BUY	$4.0 - $6.54 $58,920 - $96,334	14,730	14,730 $61,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Prism Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Prism Advisors, Inc. with notifications on news.